Showing results (4391-4400 of 45,233) with videos related to
Sort By:
Pageof 4,524
Cancer Research|March 5, 2004
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinomaKirsten Struckmann, Peter Schraml, Ronald Simon, et al.Cancer Research|March 5, 2004
A genetically defined model for human ovarian cancerJinsong Liu, Gong Yang, Jennifer A Thompson-Lanza, et al.Cancer Research|March 5, 2004
Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesisMingzhao Xing, Yoram Cohen, Elizabeth Mambo, et al.Cancer Research|March 5, 2004
Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18Gero Kramer, Hamdiye Erdal, Helena J M M Mertens, et al.Cancer Research|March 5, 2004
Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancerYusuke Mizukami, Jingnan Li, Xiaobo Zhang, et al.Cancer Research|March 5, 2004
Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-riboseYuichi Nakajima, Takenari Gotanda, Hiroshi Uchimiya, et al.Cancer Research|March 5, 2004
Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotypeJun Wang, Liqiang Xi, Jennifer L Hunt, et al.Cancer Research|April 3, 2004
Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortiumAlexander Yu Nikitin, Ana Alcaraz, Miriam R Anver, et al.Cancer Research|April 3, 2004
Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitroPeter J Houghton, Glen S Germain, Franklin C Harwood, et al.Cancer Research|April 3, 2004
p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosisS Perwez Hussain, Paul Amstad, Peijun He, et al.Pageof 4,524